TABLE 2.
Chromosome | Position | Reference | Variant | Allele Call | Type | Allele Source | Gene ID |
---|---|---|---|---|---|---|---|
Father | |||||||
Chr 11 | 534242 | A | G | Heterozygous | SNP | Novel | HRAS |
Chr4 | 1807894 | G | A | Homozygous | SNP | Novel | FGFR3 |
Chr5 | 1494533049 | G | A | Heterozygous | SNP | Novel | CSFIR |
Chr7 | 55249063 | G | A | Homozygous | SNP | Novel | EGFR |
Chr10 | 43613843 | G | T | Homozygous | SNP | Novel | RET |
Chr13 | 28610183 | A | G | Homozygous | SNP | Novel | FLT3 |
Patient | |||||||
Chr 11 | 534242 | A | G | Heterozygous | SNP | Novel | HRAS |
Chr4 | 1807894 | G | A | Homozygous | SNP | Novel | FGFR3 |
Chr5 | 149433596 | TG | GA | Homozygous | MNP | Novel | CSFIR |
Chr7 | 55249063 | G | A | Heterozygous | SNP | Novel | EGFR |
Chr10 | 43613843 | G | T | Homozygous | SNP | Novel | RET |
Chr13 | 28610183 | A | G | Heterozygous | SNP | Novel | FLT3 |
Common novel mutations identified in nonneoplastic brain tissue shared between the patient and his father are shown. Nonneoplastic tissue from the sister was not available. Of note, HRAS is the only mutation identified in both neoplastic and nonneoplastic tissues for the patient and his father.